Disease-modifying potential of bet inhibitor pelabresib (CPI-0610) as demonstrated by improvements in bone marrow function and clinical activity in patients with myelofibrosis - preliminary Data Meeting Abstract
| Authors: | Verstovsek, S.; Salama, M. E.; Mascarenhas, J.; Talpaz, M.; Mesa, R. A.; Vannucchi, A.; Rampal, R.; Oh, S. T.; Olteanu, H.; Chiu, A.; Chen, D.; Hanson, C. A.; Curto-Garcia, N.; Taverna, P.; Cui, J. K.; Zavidij, O.; Chen, Z. H.; Colak, G.; Efuni, S.; Keller, P. J.; Trojer, P.; Harrison, C. N. |
| Abstract Title: | Disease-modifying potential of bet inhibitor pelabresib (CPI-0610) as demonstrated by improvements in bone marrow function and clinical activity in patients with myelofibrosis - preliminary Data |
| Meeting Title: | 63rd Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 138 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2021 Dec 11-14 |
| Meeting Location: | Atlanta, GA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2021-11-23 |
| Language: | English |
| ACCESSION: | WOS:000736413902084 |
| DOI: | 10.1182/blood-2021-152267 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 2568 -- Hybrid meeting, also took place online -- Source: Wos |
